Stephen A Harding1, Rana Biary2,3, Robert S Hoffman2,3, Mark K Su2,3, Mary Ann Howland3,4. 1. Division of Medical Toxicology, Henry J.N. Taub Department of Emergency Medicine, Baylor College of Medicine, 1504 Ben Taub Loop, Houston, TX, 77030, USA. harding@bcm.edu. 2. Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU School of Medicine, New York, NY, USA. 3. New York City Poison Control Center, New York, NY, USA. 4. St. John's University College of Pharmacy and Health Sciences, New York, NY, USA.
Abstract
OBJECTIVE: Although hemodialysis is recommended for patients with severe metformin-associated lactic acidosis (MALA), the amount of metformin removed by hemodialysis is poorly documented. We analyzed endogenous clearance and hemodialysis clearance in a patient with MALA. METHODS: A 62-year-old man with a history of type II diabetes mellitus presented after several days of vomiting and diarrhea and was found to have acute kidney injury (AKI) and severe acidemia. Initial serum metformin concentration was 315.34 μmol/L (40.73 μg/mL) (typical therapeutic concentrations 1-2 μg/mL). He underwent 6 h of hemodialysis. We collected hourly whole blood, serum, urine, and dialysate metformin concentrations. Blood, urine, and dialysate samples were analyzed, and clearances were determined using standard pharmacokinetic calculations. RESULTS: The total amount of metformin removed by 6 h of hemodialysis was 888 mg, approximately equivalent to one therapeutic dose. Approximately 142 mg of metformin was cleared in the urine during this time. His acid-base status and creatinine improved over the following days. No further hemodialysis was required. CONCLUSION: We report a case of MALA likely secondary to AKI and severe volume depletion. The patient improved with supportive care, sodium bicarbonate, and hemodialysis. Analysis of whole blood, serum, urine, and dialysate concentrations showed limited efficacy of hemodialysis in the removal of metformin from blood, contrary to previously published data. Despite evidence of acute kidney injury, a relatively large amount of metformin was eliminated in the urine while the patient was undergoing hemodialysis. These data suggest that clinical improvement is likely due to factors besides removal of metformin.
OBJECTIVE: Although hemodialysis is recommended for patients with severe metformin-associated lactic acidosis (MALA), the amount of metformin removed by hemodialysis is poorly documented. We analyzed endogenous clearance and hemodialysis clearance in a patient with MALA. METHODS: A 62-year-old man with a history of type II diabetes mellitus presented after several days of vomiting and diarrhea and was found to have acute kidney injury (AKI) and severe acidemia. Initial serum metformin concentration was 315.34 μmol/L (40.73 μg/mL) (typical therapeutic concentrations 1-2 μg/mL). He underwent 6 h of hemodialysis. We collected hourly whole blood, serum, urine, and dialysate metformin concentrations. Blood, urine, and dialysate samples were analyzed, and clearances were determined using standard pharmacokinetic calculations. RESULTS: The total amount of metformin removed by 6 h of hemodialysis was 888 mg, approximately equivalent to one therapeutic dose. Approximately 142 mg of metformin was cleared in the urine during this time. His acid-base status and creatinine improved over the following days. No further hemodialysis was required. CONCLUSION: We report a case of MALA likely secondary to AKI and severe volume depletion. The patient improved with supportive care, sodium bicarbonate, and hemodialysis. Analysis of whole blood, serum, urine, and dialysate concentrations showed limited efficacy of hemodialysis in the removal of metformin from blood, contrary to previously published data. Despite evidence of acute kidney injury, a relatively large amount of metformin was eliminated in the urine while the patient was undergoing hemodialysis. These data suggest that clinical improvement is likely due to factors besides removal of metformin.
Entities:
Keywords:
Biguanides; Drug clearance; Hemodialysis; Lactic acidosis; Metformin
Authors: Felicity C Smith; Shaun S Kumar; Timothy J Furlong; Suraj V Gangaram; Jerry R Greenfield; Sophie L Stocker; Garry G Graham; Kenneth M Williams; Richard O Day Journal: Am J Kidney Dis Date: 2016-10-15 Impact factor: 8.860
Authors: Stephanie H Hernandez; Maryann Howland; Thomas D Schiano; Robert S Hoffman Journal: Clin Toxicol (Phila) Date: 2015-10-20 Impact factor: 4.467
Authors: Diane P Calello; Kathleen D Liu; Timothy J Wiegand; Darren M Roberts; Valéry Lavergne; Sophie Gosselin; Robert S Hoffman; Thomas D Nolin; Marc Ghannoum Journal: Crit Care Med Date: 2015-08 Impact factor: 7.598
Authors: Paul Ayoub; Pierre-Olivier Hétu; Monique Cormier; Alexandre Benoit; Andrea Palumbo; Marie-Claude Dubé; Sophie Gosselin; Marc Ghannoum Journal: Kidney Int Rep Date: 2017-03-07